Table 1.
Characteristics of the S. aureus DFI isolates used in this study.
| Strain Characteristics | S. aureus DFI Isolates | |||
|---|---|---|---|---|
| Z5.2 | Z16.1 | Z21.3 | Z25.2 | |
| mecA | − | + | + | − |
| coa | + | + | + | + |
| spa | + | + | + | + |
| clfa | + | + | + | + |
| icaA | + | + | + | + |
| icaD | + | + | + | + |
| bap | − | − | − | − |
| pvl | − | − | − | − |
| agrI | + | − | − | + |
| agrII | − | + | + | − |
| tst | − | − | − | − |
| ST | 72 | 105 | 2599 | 944 |
| CC | 5 | 5 | 5 | 182 |
| Antimicrobial resistance profile | − | Fox, Cip, Ery | Fox, Cyp, Ery | − |
| Biofilm-forming ability | Moderate at 24 h | Moderate at 24 h | Moderate at 24 h | Moderate at 48 h |
Z—swab sample, mecA—methicillin resistance gene, coa—coagulase gene, spa—protein A gene, clfa—clumping factor a gene, icaA and icaD—adhesin genes, bap—biofilm associated protein gene, pvl—panton-valentine leucocidin gene, agrI and agrII—accessory regulators genes, tst—toxic shock syndrome toxin 1 gene, ST—sequence type, CC—clonal complex, Fox—cefoxitin, Cyp—ciprofloxacin, Ery—erythromycin, +—positive, −—negative.